Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
6
Mins
29 Feb 2024
Review of the European Association for Haemophilia and Allied Disorders (EAHAD) Annual Congress 2024
The congress featured an enthusiastic welcome from 2024 EAHAD Congress President, Wolfgang Miesbach, who discussed the ongoing innovation…
4
Mins
29 Feb 2024
Optimising Outcomes of Haemophilia Treatment
The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place in Frankfurt, Germany, from…
28 Feb 2024
EAHAD 2024 - Key Reflections from the Congress President
Live from EAHAD 2024, Wolfgang Miesbach, Congress President, shares a glimpse of the event, emphasises stand-out sessions from the…
26 Feb 2024
Treatment Delays in Acute Lymphoblastic Leukaemia Following COVID-19
A new retrospective study from St. Jude Children’s Research Hospital, Memphis, Tennessee, USA, reports treatment delays in young patients with acute lymphoblastic leukaemia (ALL) following COVID-19 diagnosis.
21 Feb 2024
CME-accredited Webinar: The Use of Angiotensin II in Vasodilatory Shock
A CME-accredited webinar covers vasodilatory shock, the current vasoactive agents, and acritical evaluation of emerging therapies.
9
Mins
25 Jan 2024
The AZALEA-TIMI 71 Study and the Future of Factor XI Inhibition: Reflections from the American Heart Association Scientific Congress 2023
Since its earliest days, the effective use of anticoagulation for prevention of stroke and other thromboembolic events has been limited by…
3
Mins
15 Jan 2024
Interview with the EAHAD Congress President: Wolfgang Miesbach
Wolfgang Miesbach, Professor of Medicine, Frankfurt University Hospital, Germany; Congress President, European Association for Haemophilia…
4 Jan 2024
Equal Access to Haematological Diagnostics
Elizabeth Macintyre discusses her EHA presidency, and the importance of equal access to diagnostics in haematology.
Loading posts...
« Previous
1
…
48
49
50
51
52
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View